| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_382ccfc2ebebcaee15aa7cda4cee86bc |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y102-01009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-686
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6886 |
| filingDate |
2017-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_168e41b3a612706814af237fccc51f64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a75e4864cdf59d5bbc51664b00356ddf
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff6506765f54c3db08c362b8fb60f5ac
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1f7187241f442a30e6f97a1d55e5e241 |
| publicationDate |
2019-03-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-109477148-A |
| titleOfInvention |
Auxiliary method for determination of hematological stage of acute lymphoblastic leukemia in children |
| abstract |
The present invention provides a method for assisting the determination of the hematological stage of childhood acute lymphoblastic leukemia (childhood ALL), and an in vitro diagnostic drug that can be used for the method. The present invention is a method for assisting the determination of the hematological stage of childhood ALL, comprising the steps of: (1) obtaining Wilms' tumor in at least any biological sample of peripheral blood and bone marrow fluid of a subject 1 step of the mRNA amount of the gene (WT1); (2) the step of obtaining the GAPDH mRNA amount in the same sample above; and (3) based on the WT1 mRNA amount and GAPDH obtained in the steps (1) and (2) above, respectively A step of calculating the index value necessary for assisting the determination based on the ratio of the amount of mRNA. |
| priorityDate |
2016-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |